These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 11577366)

  • 1. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiviral prophylaxis].
    Graubner UB
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
    Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
    Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinations for adult solid organ transplant recipient: current recommendations.
    Ballout A; Goffin E; Yombi JC; Vandercam B
    Transplant Proc; 2005; 37(6):2826-7. PubMed ID: 16182821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
    Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
    Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Cordonnier C; de Bock R; Einsele H; Engelhard D; Grundy J; Link H; Locasciulli A; Prentice G; Reusser P
    Bone Marrow Transplant; 1995 Mar; 15(3):455-60. PubMed ID: 7599572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of immunity for vaccine--preventable diseases in children after hematopoietic stem cells transplantation.
    Goździk J; Czajka H; Paradowska-Stankiewicz I; Skoczeń S; Czogała W; Krasowska-Kwiecień A; Wiecha O
    Przegl Epidemiol; 2012; 66(1):93-8. PubMed ID: 22708306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on universal childhood immunizations.
    Hamlin J; Senthilnathan S; Bernstein HH
    Curr Opin Pediatr; 2008 Aug; 20(4):483-9. PubMed ID: 18622208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
    Engelhard D; Nagler A; Hardan I; Morag A; Aker M; Baciu H; Strauss N; Parag G; Naparstek E; Ravid Z
    Bone Marrow Transplant; 1993 Jan; 11(1):1-5. PubMed ID: 8431706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Thilo W; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Oct; 60(7):195-8. PubMed ID: 1434337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.